Indica Labs has announced their latest webinar. Tumor-specific Tumor-resident Cytotoxic T Cells Predict Recurrence In Stage III Melanoma Patients Treated With Adjuvant Immunotherapy 20 January 2022 2:00pm - 3:00pm PST | 5:00pm -...

Leveraging each other’s expertise in digital pathology and deep learning AI, Mayo Clinic and Aiforia aim to enable faster results and scalable studies in translational research. January 12, 2022 -- Aiforia, a technology company providing...

Collaboration expected to accelerate identification of patients with an elevated risk for cancer MENLO PARK, Calif. and CHARLOTTE, N.C., January 10, 2022 — GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it...

Albuquerque, NM, 10 January, 2022 – Indica Labs, a leading provider of computational pathology software and services, is proud to announce that following ISO13485 certification, HALO AP® has received a CE Mark for use in primary diagnosis...

A Deep Learning Convolutional Neural Network Can Differentiate Between Helicobacter Pylori Gastritis and Autoimmune Gastritis with Results Comparable to Gastrointestinal Pathologists 13 January 2022 8:00 - 9:00 PST | 11:00 - 12:00 EST |...

Jan 5, 2022 - Combining robotic-assisted bronchoscopy with rapid on-site evaluation by cytopathologists enables cancer evaluation and diagnosis in one procedure New technologies are making it possible to both collect a tissue biopsy and...